
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
Author(s) -
Luther A. Bartelt,
Alena J. Markmann,
Bridget Nelson,
Jessica Keys,
Heather T. Root,
Heather I Henderson,
JoAnn Kuruc,
Caroline Baker,
Debaleena Bhowmik,
Yixuan J. Hou,
Lakshmanane Premkumar,
Caleb Cornaby,
John L. Schmitz,
Susan R. Weiss,
Yara Park,
Ralph S. Baric,
Aravinda M. de Silva,
Anne Lachiewicz,
Sonia Napravnik,
David van Duin,
David M. Margolis
Publication year - 2022
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/27bq-xc46
Subject(s) - convalescent plasma , virology , neutralizing antibody , titer , covid-19 , antibody , coronavirus , medicine , antibody titer , virus , immunology , infectious disease (medical specialty) , disease , outbreak